Insider Trades
News
globenewswire.comEquillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.comJun 2
seekingalpha.comEquillium, Inc. (EQ) Discusses Mechanistic Insights Linking AhR Signaling and miR-124 in Inflammatory Disease Transcriptseekingalpha.comJun 1
marketbeat.comEquillium Links AhR Activation to miR-124 as EQ504 Heads Toward Phase 1marketbeat.comMay 29
globenewswire.comEquillium to Participate in the 2026 Jefferies Global Healthcare Conferenceglobenewswire.comMay 28
globenewswire.comEquillium to Host Virtual Investor Event to Share New Insights into the Aryl Hydrocarbon Receptor (AhR) and miR-124 Axisglobenewswire.comMay 20